Literature DB >> 14993354

The GoLoco motif: heralding a new tango between G protein signaling and cell division.

Randall J Kimple1, Francis S Willard, David P Siderovski.   

Abstract

The Galpha and Gbetagamma components of heterotrimeric G proteins, typically associated with cell-surface receptor signaling, also partake in the macromolecular interactions that underlie cell polarity and cell division. Proteins with Galpha-binding GoLoco motifs, such as Drosophila melanogaster Pins (for Partner of Inscuteable) and its mammalian counterpart LGN, participate in multi-protein complexes that maintain cellular asymmetry and orderly segregation of chromosomal content and daughter cell bodies. The GoLoco motif was recently identified as a selective Galpha-binding partner: the GoLoco-Galpha interaction can displace Gbetagamma and inhibit guanine nucleotide release from the bound Galpha subunit. Recent x-ray crystallographic studies suggest ways in which GoLoco-motif peptides may modulate heterotrimeric G protein signaling. Such peptides could be exploited to help dissect the signals that underpin cell polarity and cell division processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14993354     DOI: 10.1124/mi.2.2.88

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  11 in total

1.  Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule.

Authors:  Akiyuki Nishimura; Ken Kitano; Jun Takasaki; Masatoshi Taniguchi; Norikazu Mizuno; Kenji Tago; Toshio Hakoshima; Hiroshi Itoh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

2.  A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interaction.

Authors:  Adam J Kimple; Adam Yasgar; Mark Hughes; Ajit Jadhav; Francis S Willard; Robin E Muller; Christopher P Austin; James Inglese; Gordon C Ibeanu; David P Siderovski; Anton Simeonov
Journal:  Comb Chem High Throughput Screen       Date:  2008-06       Impact factor: 1.339

Review 3.  Antibodies against G-protein coupled receptors: novel uses in screening and drug development.

Authors:  Achla Gupta; Andrea S Heimann; Ivone Gomes; Lakshmi A Devi
Journal:  Comb Chem High Throughput Screen       Date:  2008-07       Impact factor: 1.339

4.  Nucleobindin 1 is a calcium-regulated guanine nucleotide dissociation inhibitor of G{alpha}i1.

Authors:  Neeraj Kapoor; Ruchi Gupta; Santosh T Menon; Ewa Folta-Stogniew; Daniel P Raleigh; Thomas P Sakmar
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

5.  Molecular characterization of specific H1-receptor agonists histaprodifen and its Nalpha-substituted analogues on bovine aortic H1-receptors.

Authors:  Marija Carman-Krzan; Aljosa Bavec; Matjaz Zorko; Walter Schunack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-25       Impact factor: 3.000

6.  Guanine nucleotide dissociation inhibitor activity of the triple GoLoco motif protein G18: alanine-to-aspartate mutation restores function to an inactive second GoLoco motif.

Authors:  Randall J Kimple; Francis S Willard; Melinda D Hains; Miller B Jones; Gift K Nweke; David P Siderovski
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

7.  The proline-rich N-terminal domain of G18 exhibits a novel G protein regulatory function.

Authors:  Peishen Zhao; Chau H Nguyen; Peter Chidiac
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

8.  GoLoco motif proteins binding to Galpha(i1): insights from molecular simulations.

Authors:  Kamil Khafizov
Journal:  J Mol Model       Date:  2009-05-14       Impact factor: 1.810

Review 9.  Submembraneous microtubule cytoskeleton: regulation of microtubule assembly by heterotrimeric Gproteins.

Authors:  Sukla Roychowdhury; Mark M Rasenick
Journal:  FEBS J       Date:  2008-08-27       Impact factor: 5.542

Review 10.  The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits.

Authors:  David P Siderovski; Francis S Willard
Journal:  Int J Biol Sci       Date:  2005-04-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.